Emergent Stock Buy Hold or Sell Recommendation


USD 29.72  0.83  2.72%   

Considering the 90-day investment horizon and your way above-average risk tolerance, our recommendation regarding Emergent Biosolutions is 'Hold'. Macroaxis provides Emergent Biosolutions buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding EBS positions. The advice algorithm takes into account all of Emergent Biosolutions' available fundamental, technical, and predictive indicators you will find on this site.
The advice is provided from Emergent Biosolutions' buy-and-hold perspective. Continue to Emergent Biosolutions Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. We conduct extensive research on individual companies such as Emergent and provide practical buy, sell, or hold advice based on selected investing horizon and risk tolerance towards Emergent Biosolutions.

Execute Emergent Biosolutions Buy or Sell Advice

The Emergent recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Emergent Biosolutions. Macroaxis does not own or have any residual interests in Emergent Biosolutions or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Emergent Biosolutions' advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell Emergent BiosolutionsBuy Emergent Biosolutions


Not too volatileDetails

Hype Condition

Low keyDetails

Current Valuation


Odds of Distress

Below AverageDetails

Economic Sensitivity

Responds to the marketDetails

Analyst Consensus


Financial Strenth (F Score)


Financial Leverage


Reporting Quality (M-Score)

Unlikely ManipulatorDetails
For the selected time horizon Emergent Biosolutions has a Risk Adjusted Performance of 9.0E-4, Jensen Alpha of (0.013013), Total Risk Alpha of 0.0126 and Treynor Ratio of (0.020697)
Our investment recommendation module complements current analysts and expert consensus on Emergent Biosolutions. It analyzes the firm potential to grow using all fundamental, technical, and market related data available at the time. To make sure Emergent Biosolutions is not overpriced, please confirm all Emergent Biosolutions fundamentals, including its cash per share, beta, and the relationship between the revenue and cash flow from operations . Given that Emergent Biosolutions has a number of shares shorted of 3.44 M, we urge you to verify Emergent Biosolutions market performance and probability of bankruptcy to ensure the company can sustain itself in the current economic cycle given your prevailing risk tolerance and investing horizon.

Emergent Biosolutions Trading Alerts and Improvement Suggestions

Emergent Biosolutions has very high historical volatility over the last 90 days
Emergent Biosolutions was previously known as EMERGENT BIOSOLUTIONS INC and was traded on New York Stock Exchange under the symbol EBS.
Emergent Biosolutions has a strong financial position based on the latest SEC filings
Over 88.0% of the company shares are held by institutions such as insurance companies
Latest headline from www.nasdaq.com: Leidos Holdings Seems To Use Debt Quite Sensibly - Nasdaq

Emergent Biosolutions current analysts advice

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Emergent analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Emergent analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target Mean Price44.33
Target Median Price41.50
Target High Price65.00
Recommendation Mean2.50
Number Of Analyst Opinions6
Target Low Price30.00
Average Consensus Hold
The consensus estimates and target price estimation comprises individual analyst assessments, and may or may not mutch the Macroaxis buy or sell advice. It is determined by taking an average of all analyst recommendations and classifying them as Strong Buy, Buy, Hold, or Sell.

Emergent Biosolutions Returns Distribution Density

The distribution of Emergent Biosolutions' historical returns is an attempt to chart the future uncertainty of Emergent Biosolutions' future price movements. The chart of the probability distribution of Emergent Biosolutions stock daily returns describes the distribution of returns around its average expected value. We use Emergent Biosolutions price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Emergent Biosolutions returns is essential to provide solid investment advice for Emergent Biosolutions stock.
Mean Return-0.02Value At Risk-7.08
Potential Upside7.19Standard Deviation4.56
   Return Density   
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Emergent Biosolutions historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

Emergent Biosolutions Cash Flow Accounts

201720182019202020212022 (projected)
Capital Expenditure(54.8 M)(72.1 M)(86.9 M)(141 M)(225 M)(230.92 M)
Depreciation Amortization and Accretion42.6 M62.2 M110.7 M114.5 M123.8 M133.57 M
Net Cash Flow or Change in Cash and Cash Equivalents(93.2 M)(66.9 M)55.6 M453.5 M(45.2 M)(46.39 M)
Issuance Purchase of Equity Shares(13.8 M)15.8 M8.2 M31.6 M(90.1 M)(92.47 M)
Net Cash Flow from Financing(51.4 M)788.7 M(35.9 M)69.5 M(141 M)(144.71 M)
Net Cash Flow from Investing(249.9 M)(897.2 M)(96.9 M)(151 M)(225 M)(242.76 M)
Net Cash Flow from Operations208.1 M41.8 M188 M536 M321.1 M256.01 M
Share Based Compensation15.2 M23.2 M26.7 M51 M42.4 M45.75 M

Emergent Biosolutions Greeks

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Emergent Biosolutions or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Emergent Biosolutions stock's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Emergent stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
Alpha over DOW
Beta against DOW1.60
Overall volatility
Information ratio -0.0045

Emergent Biosolutions Volatility Alert

Emergent Biosolutions exhibits very low volatility with skewness of 0.24 and kurtosis of 0.46. However, we advise investors to further study Emergent Biosolutions technical indicators to make sure all market info is available and is reliable. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Emergent Biosolutions' stock risk against market volatility during both bullying and bearish trends. The higher level of volatility that comes with bear markets can directly impact Emergent Biosolutions' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different stocks as prices fall.

Emergent Biosolutions Implied Volatility

Emergent Biosolutions' implied volatility" href="/stock-options/EBS/Emergent-Biosolutions">Emergent Biosolutions' implied volatility exposes the market's sentiment of Emergent Biosolutions stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Emergent Biosolutions' implied volatility" href="/stock-options/EBS/Emergent-Biosolutions">Emergent Biosolutions' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Emergent Biosolutions stock will not fluctuate a lot when Emergent Biosolutions' options" href="/stock-options/EBS/Emergent-Biosolutions">Emergent Biosolutions' options are near their expiration.

Emergent Biosolutions Fundamentals Vs Peers

Comparing Emergent Biosolutions' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Emergent Biosolutions' direct or indirect competition across all of the common fundamentals between Emergent Biosolutions and the related equities. This way, we can detect undervalued stocks with similar characteristics as Emergent Biosolutions or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Emergent Biosolutions' fundamental indicators could also be used in its relative valuation, which is a method of valuing Emergent Biosolutions by comparing valuation metrics with those of similar companies.
 Better Than Average     
 Worse Than Average Compare Emergent Biosolutions to competition
FundamentalsEmergent BiosolutionsPeer Average
Return On Equity10.17 %(0.31) %
Return On Asset6.77 %(0.14) %
Profit Margin8.96 %(1.27) %
Operating Margin17.50 %(5.51) %
Current Valuation2.17 B16.62 B
Shares Outstanding53.8 M571.82 M
Shares Owned by Insiders10.10 %10.09 %
Shares Owned by Institutions87.93 %39.21 %
Number of Shares Shorted3.44 M4.71 M
Price to Earning7.56 X28.72 X
Price to Book1.12 X9.51 X
Price to Sales0.97 X11.42 X
Revenue1.76 B9.43 B
Gross Profit804.1 M27.38 B
EBITDA427.9 M3.9 B
Net Income157.5 M570.98 M
Cash and Equivalents436 M2.7 B
Cash per Share8.68 X5.01 X
Total Debt861.5 M5.32 B
Debt to Equity0.55 %48.70 %
Current Ratio4.41 X2.16 X
Book Value Per Share28.36 X1.93 K
Cash Flow from Operations278.7 M971.22 M
Short Ratio6.16 X4.00 X
Earnings Per Share4.18 X3.12 X
Price to Earnings To Growth(1.45) X4.89 X
Number of Employees2.42 K18.84 K
Market Capitalization1.7 B19.03 B
Total Asset1.04 B29.47 B
Retained Earnings379.1 M9.33 B
Working Capital437.8 M1.48 B
Current Asset537.41 M9.34 B
   Acquisition by Dayal Sujata Tyagi of 11852 shares of Emergent Biosolutions subject to Rule 16b-3 [view details]

About Emergent Biosolutions Buy or Sell Advice

When is the right time to buy or sell Emergent Biosolutions? Buying financial instruments such as Emergent Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the stock market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Although Emergent Biosolutions investors may find it confusing at the beginning, most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
 2019 2020 2021 2022 (projected)
Receivables270.7 M230.9 M274.7 M296.39 M
Inventories222.5 M307 M350.8 M378.49 M

Use Investing Ideas to Build Portfolios

In addition to having Emergent Biosolutions in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run USD Crypto Assets Thematic Idea Now

USD Crypto Assets
USD Crypto Assets Theme
An experimental p2p digital currency that is accepted by many vendors in US Dollar. The USD Crypto Assets theme has 0 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize USD Crypto Assets Theme or any other thematic opportunities.
View All  Next Launch
Continue to Emergent Biosolutions Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note that the Emergent Biosolutions information on this page should be used as a complementary analysis to other Emergent Biosolutions' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Stock Screener module to find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..

Complementary Tools for Emergent Stock analysis

When running Emergent Biosolutions price analysis, check to measure Emergent Biosolutions' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Emergent Biosolutions is operating at the current time. Most of Emergent Biosolutions' value examination focuses on studying past and present price action to predict the probability of Emergent Biosolutions' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Emergent Biosolutions' price. Additionally, you may evaluate how the addition of Emergent Biosolutions to your portfolios can decrease your overall portfolio volatility.
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Bond Directory
Find actively traded corporate debentures issued by US companies
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Is Emergent Biosolutions' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Emergent Biosolutions. If investors know Emergent will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Emergent Biosolutions listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
Market Capitalization
1.5 B
Quarterly Revenue Growth YOY
Return On Assets
Return On Equity
The market value of Emergent Biosolutions is measured differently than its book value, which is the value of Emergent that is recorded on the company's balance sheet. Investors also form their own opinion of Emergent Biosolutions' value that differs from its market value or its book value, called intrinsic value, which is Emergent Biosolutions' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Emergent Biosolutions' market value can be influenced by many factors that don't directly affect Emergent Biosolutions' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Emergent Biosolutions' value and its price as these two are different measures arrived at by different means. Investors typically determine Emergent Biosolutions value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Emergent Biosolutions' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.